国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Macaca fascicularis Protein FAM220A (FAM220A) CSB-YP709076MOV
CSB-EP709076MOV
CSB-BP709076MOV
CSB-MP709076MOV
CSB-EP709076MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis TATA-box-binding protein (TBP) CSB-YP709077MOV
CSB-EP709077MOV
CSB-BP709077MOV
CSB-MP709077MOV
CSB-EP709077MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Coatomer subunit beta' (COPB2), partial CSB-YP709078MOV
CSB-EP709078MOV
CSB-BP709078MOV
CSB-MP709078MOV
CSB-EP709078MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Complexin-1 (CPLX1) CSB-YP709079MOV
CSB-EP709079MOV
CSB-BP709079MOV
CSB-MP709079MOV
CSB-EP709079MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Heat shock protein HSP 90-alpha (HSP90AA1), partial CSB-YP709080MOV
CSB-BP709080MOV
CSB-MP709080MOV
CSB-EP709080MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Protein MTO1 homolog, mitochondrial (MTO1), partial CSB-YP709081MOV
CSB-EP709081MOV
CSB-BP709081MOV
CSB-MP709081MOV
CSB-EP709081MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Nuclear distribution protein nudE-like 1 (NDEL1) CSB-YP709082MOV
CSB-EP709082MOV
CSB-BP709082MOV
CSB-MP709082MOV
CSB-EP709082MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Ran-binding protein 3 (RANBP3) CSB-YP709083MOV
CSB-EP709083MOV
CSB-BP709083MOV
CSB-MP709083MOV
CSB-EP709083MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Ataxin-10 (ATXN10) CSB-YP709084MOV
CSB-EP709084MOV
CSB-BP709084MOV
CSB-MP709084MOV
CSB-EP709084MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Bladder cancer-associated protein (BLCAP), partial CSB-YP709085MOV1
CSB-EP709085MOV1
CSB-BP709085MOV1
CSB-MP709085MOV1
CSB-EP709085MOV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Ankyrin repeat and SOCS box protein 8 (ASB8) CSB-YP709086MOV
CSB-EP709086MOV
CSB-BP709086MOV
CSB-MP709086MOV
CSB-EP709086MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis 14-3-3 protein beta/alpha (YWHAB) CSB-YP709087MOV
CSB-EP709087MOV
CSB-BP709087MOV
CSB-MP709087MOV
CSB-EP709087MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis ATP synthase subunit gamma, mitochondrial (ATP5F1C) CSB-YP709088MOV
CSB-EP709088MOV
CSB-BP709088MOV
CSB-MP709088MOV
CSB-EP709088MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Endoplasmic reticulum-Golgi intermediate compartment protein 2 (ERGIC2), partial CSB-YP709089MOV1
CSB-EP709089MOV1
CSB-BP709089MOV1
CSB-MP709089MOV1
CSB-EP709089MOV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis YTH domain family protein 2 (YTHDF2), partial CSB-YP709090MOV
CSB-EP709090MOV
CSB-BP709090MOV
CSB-MP709090MOV
CSB-EP709090MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Iron-sulfur cluster assembly 1 homolog, mitochondrial (ISCA1) CSB-YP709091MOV
CSB-EP709091MOV
CSB-BP709091MOV
CSB-MP709091MOV
CSB-EP709091MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Visinin-like protein 1 (VSNL1) CSB-YP709092MOV
CSB-EP709092MOV
CSB-BP709092MOV
CSB-MP709092MOV
CSB-EP709092MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis 60S ribosomal protein L18 (RPL18) CSB-YP709093MOV
CSB-EP709093MOV
CSB-BP709093MOV
CSB-MP709093MOV
CSB-EP709093MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Aspartate aminotransferase, cytoplasmic (GOT1) CSB-YP709094MOV
CSB-EP709094MOV
CSB-BP709094MOV
CSB-MP709094MOV
CSB-EP709094MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Ras-related protein Rab-8A (RAB8A) CSB-YP709095MOV
CSB-EP709095MOV
CSB-BP709095MOV
CSB-MP709095MOV
CSB-EP709095MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>